Prospective study of Helicobacter pylori biomarkers for gastric cancer risk among Chinese men

Cancer Epidemiology Biomarkers and Prevention

Volumn 21, Issue 12, 2012, Pages 2185-2192

  Epplein, Meira ^a   Zheng, Wei ^a   Xiang, Yong Bing ^c   Peek, Richard M ^b   Li, Honglan ^c   Correa, Pelayo ^b   Gao, Jing ^c   Michel, Angelika ^d   Pawlita, Michael ^d   Cai, Qiuyin ^a   Shu, Xiao Ou ^a  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CAGA PROTEIN; PROTEIN ANTIBODY; PROTEIN HP0305; PROTEIN HPAA; PROTEIN HYUA; PROTEIN OMP; TUMOR MARKER; UNCLASSIFIED DRUG; VACUOLATING TOXIN;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROLOGY; STOMACH CANCER;

EID: 84871318716     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-12-0792-T     Document Type: Article

References (34)

1. Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001;49:347-53.
2. Kamangar F, Dawsey SM, Blaser MJ, Perez-Perez GI, Pietinen P, Newschaffer CJ, et al. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity. [see comment]. J Nat Cancer Inst 2006;98:1445-52. (Pubitemid 44605589)
3. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-9.
4. World Health Organization, International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans: schistosomes, liver flukes, and Helicobacter pylori. Vol. 61. Lyon, France: IARC; 1994.
5. Jemal A, Bray F, CenterMM,Ferlay J, Ward E, FormanD. Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
6. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002;347:1175-86.
7. Hatakeyama M, Higashi H. Helicobacter pylori CagA: a new paradigm for bacterial carcinogenesis. Cancer Sci 2005;96:835-43. (Pubitemid 43056121)
8. Peek RM Jr, Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2002;2:28-37. (Pubitemid 37328805)
9. Pinto-Santini D, Salama NR. The biology of Helicobacter pylori infection, a major risk factor for gastric adenocarcinoma. Cancer Epidemiol Biomarkers Prev 2005;14:1853-58. (Pubitemid 41161188)
10. Fock KM, Talley N, Moayyedi P, Hunt R, Azuma T, Sugano K, et al. Asia-Pacific consensus guidelines on gastric cancer prevention. J Gastroenterol Hepatol 2008;23:351-65. (Pubitemid 351342074)
11. Michel A, Waterboer T, Kist M, Pawlita M. Helicobacter pylori multiplex serology. Helicobacter 2009;14:525-35.
12. Bumann D, Jungblut PR, Meyer TF. Helicobacter pylori vaccine development based on combined subproteome analysis. Proteomics 2004;4:2843-8. (Pubitemid 39372372)
13. Haas G, Karaali G, Ebermayer K, Metzger WG, Lamer S, Zimny-Arndt U, et al. Immunoproteomics of Helicobacter pylori infection and relation to gastric disease. Proteomics 2002;2:313-24. (Pubitemid 34269985)
14. Krah A, Miehlke S, Pleissner KP, Zimny-Arndt U, Kirsch C, Lehn N, et al. Identification of candidate antigens for serologic detection of Helicobacter pylori-infected patients with gastric carcinoma. Int J Cancer 2004;108:456-63. (Pubitemid 37549613)
15. Gao L, Michel A, Weck MN, Arndt V, Pawlita M, Brenner H. Helicobacter pylori infection and gastric cancer risk: evaluation of 15 H. pylori proteins determined by novel multiplex serology. Cancer Res 2009;69:6164-70.
16. Cai H, Zheng W, Xiang YB, Xu WH, Yang G, Li H, et al. Dietary patterns and their correlates among middle-aged and elderly Chinese men: a report from the Shanghai Men's Health Study. Br J Nutr 2007;98:1006-13. (Pubitemid 47543460)
17. Lee SA, Wen W, Xu WH, Zheng W, Li H, Yang G, et al. Prevalence of obesity and correlations with lifestyle and dietary factors in Chinese men. Obesity (Silver Spring) 2008;16:1440-7. (Pubitemid 351770534)
18. Zheng W, Chow WH, Yang G, Jin F, Rothman N, Blair A, et al. The Shanghai Women's Health Study: rationale, study design, and baseline characteristics. Am J Epidemiol 2005;162:1123-31. (Pubitemid 41746625)
19. Cavaleiro-Pinto M, Peleteiro B, Lunet N, Barros H. Helicobacter pylori infection and gastric cardia cancer: systematic review and meta-analysis. Cancer Causes Control 2011;22:375-87.
20. Waterboer T, Sehr P, Michael KM, Franceschi S, Nieland JD, Joos TO, et al. Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins. Clin Chem 2005;51:1845-53. (Pubitemid 41368175)
21. Waterboer T, Sehr P, Pawlita M. Suppression of non-specific binding in serological Luminex assays. J Immunol Methods 2006;309:200-4. (Pubitemid 43190816)
22. Epplein M, Signorello LB, Zheng W, Peek RM Jr, Michel A, Williams SM, et al. Race, African ancestry, and Helicobacter pylori infection in a low-income United States population. Cancer Epidemiol Biomarkers Prev 2011;20:826-34.
23. Correa P, Cuello C, Duque E, Burbano LC, Garcia FT, Bolanos O, et al. Gastric cancer in Colombia. III. Natural history of precursor lesions. J Natl Cancer Inst 1976;57:1027-35.
24. de Sablet T, Piazuelo MB, Shaffer CL, Schneider BG, Asim M, Chaturvedi R, et al. Phylogeographic origin of Helicobacter pylori is a determinant of gastric cancer risk. Gut 2011;60:1189-95.
25. Abnet CC, Zheng W, Ye W, Kamangar F, Ji BT, Persson C, et al. Plasma pepsinogens, antibodies against Helicobacter pylori, and risk of gastric cancer in the Shanghai Women's Health Study Cohort. Br J Cancer 2011;104:1511-6.
26. Shiota S, Matsunari O, Watada M, Yamaoka Y. Serum Helicobacter pylori CagA antibody as a biomarker for gastric cancer in east-Asian countries. Future Microbiol 2010;5:1885-93.
27. Fuccio L, Zagari RM, Eusebi LH, Laterza L, Cennamo V, Ceroni L, et al. Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? Ann Intern Med 2009;151:121-8.
28. Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004;291:187-94. (Pubitemid 38082812)
29. Ma JL, Zhang L, Brown LM, Li JY, Shen L, Pan KF, et al. Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. J Natl Cancer Inst 2012;104:488-92.
30. Karnes WE Jr, Samloff IM, Siurala M, Kekki M, Sipponen P, Kim SW, et al. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology 1991;101:167-74.
31. Forman D, Webb P, Parsonnet J. H pylori and gastric cancer. Lancet 1994;343:243-4.
32. Correa P, Houghton J. Carcinogenesis of Helicobacter pylori. Gastroenterology 2007;133:659-72. (Pubitemid 47187360)
33. Epplein M, Shu XO, Xiang YB, Chow WH, Yang G, Li HL, et al. Fruit and vegetable consumption and risk of distal gastric cancer in the Shanghai Women's and Men's Health studies. Am J Epidemiol 2010;172:397-406.
34. Wong HL, Rabkin CS, Shu XO, Pfeiffer RM, Cai Q, Ji BT, et al. Systemic cytokine levels and subsequent risk of gastric cancer in Chinese Women. Cancer Sci 2011;102:1911-5.